Giannakos is the medication safety officer for Option Care Health, the largest home infusion company in the US, and brings more than 2 decades of experience across acute care and home infusion practice. She is dually board certified through the Board of Pharmacy Specialties, with research interests focused on medication safety in home infusion practice, particularly within infectious disease.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
September 16th 2026